Ryman Healthcare Ltd RYM

Morningstar Rating

Unlock

NZD 4.25 +0.02 (0.47%)

View Full Chart

As of Apr 24, 2024 4:44am Delayed Price Post-Trading: —

Unlock our analysis with Morningstar Investor

Start Free Trial

Company Report

View Archive

Ryman Healthcare: Tough Conditions but Long-Term Outlook Remains Solid

Alexander Prineas Apr 8, 2024

Conditions remain tough for narrow-moat Ryman Healthcare. Management downgraded fiscal 2024 underlying profit guidance to NZD 265 million-NZD 285 million in February, down from NZD 300 million-NZD 330 million. Our forecasts are unchanged, with our fiscal 2024 underlying profit forecast of NZD 269 million sitting at the lower end of the reduced guidance. Our fair value estimate remains NZD 9.60, and Ryman securities screen as significantly undervalued.

Read Full Report

Price vs Fair Value

View History

RYM is trading at a 56% discount.

Price

NZD 4.23

Apr 23, 2024

Fair Value

NZD 1.60

Nov 29, 2023

Uncertainty

Medium

1-Star Price: NZD 24.31
5-Star Price: NZD 2.16
Economic Moat: Cbsblp
Capital Allocation: Rhmyrnxym

Bulls Say, Bears Say

Bulls

Ryman’s reputation for providing quality care and high standards allows the firm to attract residents and retain industry leading occupancy rates.

Bears

Ryman’s earnings are materially exposed to fluctuations in residential property prices and a prolonged period of negative growth or stagnation will likely lead to compressed margins and capital losses.

Is it the right time to buy, sell, or hold?

Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if RYM is a good fit for your portfolio.

Get 7 Days Free

Trading Information

Previous Close Price: NZD 4.23
Day Range: NZD 4.21–4.27
52-Week Range: NZD 4.21–6.99
Bid/Ask: NZD 4.54 / NZD 3.96
Market Cap: NZD 2.92 Bil
Volume/Avg: 225,512 / 921,262

Key Statistics

Price/Earnings (Normalized): 6.96
Price/Sales: 4.29
Dividend Yield (Trailing): —
Dividend Yield (Forward): —
Total Yield: —

Company Profile

Ryman Healthcare develops, owns, and operates retirement villages and aged-care facilities in New Zealand and Australia. Most of its villages offer a combination of independent and serviced units, alongside hospital, dementia, and rest-home care. Income is predominantly earned from aged care fees, retirement unit management fees, development margins on new units, and capital gains generated when residents vacate and Ryman resells existing units.

Sector: Healthcare
Industry: Medical Care Facilities
Stock Style Box: Mid Value
Total Number of Employees: —
Website: https://www.rymanhealthcare.co.nz

Competitors

Lendlease Group

LLC

Valuation

Metric	RYM	LLC
Price/Earnings (Normalized)	6.96	244.83
Price/Book Value	0.62	0.71
Price/Sales	4.29	0.45
Price/Cash Flow	3.50	—

Price/Earnings

RYM

LLC

Financial Strength

Metric	RYM	LLC
Quick Ratio	2.22	0.59
Current Ratio	2.51	1.02
Interest Coverage	0.12	−1.36

Quick Ratio

RYM

LLC

Profitability

Metric	RYM	LLC
Return on Assets (Normalized)	2.41%	−2.07%
Return on Equity (Normalized)	6.89%	−5.66%
Return on Invested Capital (Normalized)	3.20%	−4.06%

Return on Assets

RYM

LLC

See how this stock stacks up to its competitors with Morningstar Investor